Detalles de la búsqueda
1.
Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation.
Mod Pathol
; 37(4): 100451, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369190
2.
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.
Mod Pathol
; 35(9): 1181-1192, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641658
3.
Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERα transcriptional program and may have undergone natural selection.
Carcinogenesis
; 41(2): 146-158, 2020 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31400761
4.
Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma.
BMC Cancer
; 20(1): 248, 2020 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32209061
5.
Corrigendum to "Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma" [Modern Pathology. 2022;35(9):1181-1192].
Mod Pathol
; 37(2): 100407, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183899
6.
Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer.
FASEB J
; 29(5): 1986-98, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25667220
7.
Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility.
Tumour Biol
; 35(8): 8289-99, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24852432
8.
EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.
Target Oncol
; 19(2): 277-288, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416376
9.
Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkers.
J Hematol Oncol
; 17(1): 11, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38491392
10.
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma.
NPJ Precis Oncol
; 7(1): 80, 2023 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634047
11.
Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma.
Cell Death Dis
; 14(8): 493, 2023 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532692
12.
Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer.
Cancer Sci
; 103(6): 1121-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22404099
13.
Identification and Validation of Noncanonical RET Fusions in Non-Small-Cell Lung Cancer through DNA and RNA Sequencing.
J Mol Diagn
; 24(4): 374-385, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063667
14.
Identification and therapeutic evaluation of ALK rearrangements in non-small-cell lung cancer.
J Pathol Clin Res
; 8(6): 538-549, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35848751
15.
[Clinicopathologic correlation between CD4-positive T lymphocyte counts and superficial lymphadenopathy in HIV-positive/AIDS patients].
Zhonghua Bing Li Xue Za Zhi
; 40(9): 622-5, 2011 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-22177247
16.
YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma.
Front Oncol
; 11: 692283, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34354947
17.
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Theranostics
; 11(1): 361-378, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33391480
18.
The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Ann Transl Med
; 9(9): 779, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34268392
19.
EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma.
JTO Clin Res Rep
; 2(7): 100185, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590035
20.
Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
J Pathol Clin Res
; 7(4): 375-384, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33768710